Avita Research Development from 2010 to 2026

RCEL Stock  USD 4.31  0.15  3.61%   
Avita Medical Research Development yearly trend continues to be quite stable with very little volatility. Research Development may rise above about 21.9 M this year. From the period between 2010 and 2026, Avita Medical, Research Development regression line of its data series had standard deviation of  7,572,214 and standard deviation of  7,572,214. View All Fundamentals
 
Research Development  
First Reported
2012-03-31
Previous Quarter
3.7 M
Current Value
5.7 M
Quarterly Volatility
1.9 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Avita Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avita Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 5.3 M or Selling General Administrative of 28.7 M, as well as many indicators such as Price To Sales Ratio of 1.28, Dividend Yield of 0.0 or Days Sales Outstanding of 44.0. Avita financial statements analysis is a perfect complement when working with Avita Medical Valuation or Volatility modules.
  
Build AI portfolio with Avita Stock
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
Historical Research Development data for Avita Medical serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Avita Medical represents a compelling investment opportunity.

Latest Avita Medical's Research Development Growth Pattern

Below is the plot of the Research Development of Avita Medical over the last few years. It is Avita Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avita Medical's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Avita Research Development Regression Statistics

Arithmetic Mean10,100,006
Geometric Mean6,512,273
Coefficient Of Variation74.97
Mean Deviation6,214,931
Median10,058,265
Standard Deviation7,572,214
Sample Variance57.3T
Range21.5M
R-Value0.98
Mean Square Error3T
R-Squared0.95
Slope1,462,742
Total Sum of Squares917.4T

Avita Research Development History

202621.9 M
202520.8 M
202420.4 M
202320.8 M
202213.9 M
202115.7 M

About Avita Medical Financial Statements

Avita Medical investors utilize fundamental indicators, such as Research Development, to predict how Avita Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development20.8 M21.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. Anticipated expansion of Avita directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Avita Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.81)
Revenue Per Share
2.57
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.39)
Return On Equity
(17.46)
Investors evaluate Avita Medical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Avita Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Avita Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Avita Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Avita Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Avita Medical's market price signifies the transaction level at which participants voluntarily complete trades.